NCT07081399 the Effect of Adult Intubated Patient Clinical Pathway on Post-extubation Complications Prevention
| NCT ID | NCT07081399 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | Damanhour University |
| Condition | Dysphagia |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-08-08 |
| Primary Completion | 2025-03-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 80 participants in total. It began in 2024-08-08 with a primary completion date of 2025-03-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Post- extubation complications delay the complete recovery of critically ill patient. The clinical pathway is one strategies that help to manage and control these complications.
Eligibility Criteria
Inclusion Criteria: * Adult (\>18 years) * orally intubated patients for the first time attached with MV for less than two weeks * with Glasgow coma scale (GCS) from 13-15. Exclusion Criteria: * patients admitted with high risk for laryngeal edema, * difficult intubation, * ETT/anterior-posterior diameter ˃45%, * self-extubation, and * planned for tracheostomy.
Contact & Investigator
heba attia effect of adult intubated CP on post-extubation complications
✉ heba.attia@nur.dmu.edu.eg📞 045 01274855242
sahar youness effect of adult intubated CP on post-extubation complications
STUDY CHAIR
Frequently Asked Questions
Who can join the NCT07081399 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Dysphagia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07081399 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07081399 currently recruiting?
Yes, NCT07081399 is actively recruiting participants. Contact the research team at heba.attia@nur.dmu.edu.eg for enrollment information.
Where is the NCT07081399 trial being conducted?
This trial is being conducted at Damanhūr, Egypt.
Who is sponsoring the NCT07081399 clinical trial?
NCT07081399 is sponsored by Damanhour University. The principal investigator is sahar youness effect of adult intubated CP on post-extubation complications. The trial plans to enroll 80 participants.